$1.27
0.00%
Nasdaq, Mon, Aug 25 2025
ISIN
US4495851085
Symbol
IGMS

IGM Biosciences Inc Stock price

$1.27
+0.00 0.00% 1M
-0.04 3.05% 6M
-4.84 79.21% YTD
-9.02 87.66% 1Y
-18.93 93.71% 3Y
-44.20 97.21% 5Y
-23.03 94.77% 10Y
-23.03 94.77% 20Y
Nasdaq, Closing price Mon, Aug 25 2025
+0.00 0.00%
ISIN
US4495851085
Symbol
IGMS
Industry

Key metrics

Basic
Market capitalization
$76.6m
Enterprise Value
$-27.7m
Net debt
positive
Cash
$104.3m
Shares outstanding
60.2m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
0.5 | 8.1
EV/Sales
negative | negative
EV/FCF
0.2
P/B
0.8
Financial Health
Equity Ratio
18.1%
Return on Equity
-406.5%
ROCE
10.1%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$145.1m | $9.4m
EBITDA
$17.6m | $-86.2m
EBIT
$10.2m | $-104.2m
Net Income
$-53.0m | $-78.3m
Free Cash Flow
$-158.2m
Growth (TTM | estimate)
Revenue
4,884.5% | 252.3%
EBITDA
107.7% | 53.4%
EBIT
104.3% | 46.4%
Net Income
76.0% | 60.0%
Free Cash Flow
10.3%
Margin (TTM | estimate)
Gross
-
EBITDA
12.1% | -913.1%
EBIT
7.0%
Net
-36.5% | -828.8%
Free Cash Flow
-109.1%
More
EPS
$-0.9
FCF per Share
$-2.6
Short interest
2.1%
Employees
149
Rev per Employee
$20.0k
Show more

Is IGM Biosciences Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,019 stocks worldwide.

IGM Biosciences Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a IGM Biosciences Inc forecast:

6x Hold
67%
3x Sell
33%

Analyst Opinions

9 Analysts have issued a IGM Biosciences Inc forecast:

Hold
67%
Sell
33%

Financial data from IGM Biosciences Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
145 145
4,885% 4,885%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 39 39
13% 13%
27%
- Research and Development Expense 95 95
51% 51%
65%
18 18
108% 108%
12%
- Depreciation and Amortization 7.37 7.37
17% 17%
5%
EBIT (Operating Income) EBIT 10 10
104% 104%
7%
Net Profit -53 -53
76% 76%
-37%

In millions USD.

Don't miss a Thing! We will send you all news about IGM Biosciences Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

IGM Biosciences Inc Stock News

Neutral
Business Wire
about 2 months ago
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of IGM Biosciences, Inc. (NASDAQ: IGMS) to Concentra Biosciences, LLC is fair to IGM shareholders. Under the terms of the proposed transaction, IGM shareholders would receive $1.247 in cash per share, plus one non-tradeable contingent value right, representing the right to receive additio...
Neutral
GlobeNewsWire
about 2 months ago
MOUNTAIN VIEW, Calif., July 01, 2025 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a biotechnology company that has focused on developing engineered IgM-based therapeutic antibodies, today announced that it has entered into a definitive merger agreement (the “Merger Agreement”) with Concentra Biosciences, LLC (“Concentra”), whereby Concentra will acquire IGM Biosciences for $1.247 i...

Company Profile

IGM Biosciences, Inc. operates as a biotechnology company which develops antibodies for the treatment of cancer. It offers IgM platform to expand upon the inherent properties of IgM antibodies and to allow for the rapid development of engineered therapeutic antibodies. The firms product pipe line includes IGM-2323, which is a CD20 x CD3 bispecific IgM antibody designed to treat patients with B cell Non-Hodgkin's lymphoma and other B cell malignancies; IGM-8444, which is an IgM antibody targeting Death Receptor 5 for the treatment of patients with solid and hematologic malignancies; and IGM-7354, which will target the delivery of IL-15 with the goal of inducing immune cell stimulation and proliferation. The company was founded in 2010 and is headquartered in Mountain View, CA.

Head office United States
CEO Mary Harler
Employees 149
Founded 2010
Website igmbio.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today